Gener8 Acquires Symbient Product Development

Gener8 Acquires The RND Group

December 9, 2021

Medical Devices

Gener8 LLC, a portfolio company of Sverica Capital Management, has completed the acquisition of The RND Group, an Indianapolis-based provider of software development for medical device and life sciences products. The acquisition adds full-lifecycle regulated software capabilities — including cloud solutions, verification & validation, quality system compliance, and LIS/EHR integration — to Gener8's existing instrument, consumable and firmware offerings to extend services off-instrument and accelerate customer development timelines.

GenNx360 Capital Partners Acquires Majority Stake in Tensentric

March 18, 2022

Medical Devices

GenNx360 Capital Partners has made a majority investment in Tensentric, a Boulder-based provider of design, engineering, prototyping and assembly services for medical technology, IVD and life-sciences companies. The investment will support Tensentric's next phase of growth and enable the company to scale its services capabilities through organic and inorganic initiatives.

Summa Equity Acquires Majority Stake in Sengenics

October 14, 2020

Biotechnology

Summa Equity Fund II has acquired a majority stake in Sengenics, a functional proteomics company that commercialises the KREX technology for full‑length, correctly folded protein production and autoantibody detection. The investment will support Sengenics' product development, global expansion and accelerated commercial adoption across pharma, academic research and diagnostics.

Servier Acquires Symphogen A/S from Novo Holdings and Other Owners

April 3, 2020

Biotechnology

Servier has acquired 100% of the share capital of Symphogen A/S from Novo Holdings and the remaining owners, taking ownership of the Danish therapeutic antibody discovery and early biologics development company. The deal brings Symphogen’s antibody discovery platform and CMC biologics development capabilities into Servier’s oncology and immuno-oncology R&D efforts to strengthen its biologics pipeline and development capacity.

Salona Global Medical Device Corp. Acquires Simbex, LLC

September 30, 2021

Medical Devices

Salona Global Medical Device Corporation (SGMD) acquired Simbex, LLC, an IP-driven medical device design and product company that generated approximately US$8.0 million in 2020 revenue. The acquisition is intended to expand SGMD’s recovery-medicine product portfolio, leverage manufacturing capabilities, and increase annualized run-rate revenues to over $24 million.

Medbio (Graham Partners) Acquires Polymer Conversions

September 1, 2020

Medical Devices

Graham Partners’ portfolio company Medbio, an outsourced medical device manufacturer based in Grand Rapids, Michigan, has acquired Polymer Conversions, Inc., a Western New York contract molder. The add‑on expands Medbio’s geographic footprint and injection‑molding and assembly capabilities, creating cross‑selling opportunities and expected operational synergies for the combined medical‑device manufacturing platform.